Beta-adrenergic antagonist for the healing of chronic diabetic foot ulcers: study protocol for a prospective, randomized, double-blinded, controlled and parallel-group study

Beta-adrenergic antagonist for the healing of chronic diabetic foot ulcers: study protocol for a prospective, randomized, double-blinded, controlled and parallel-group study

Abstract Background Diabetic foot ulcers (DFUs) are the most common cause of leg amputations and their management is extremely challenging. Despite many advances and expensive therapies, there has been little success in improving outcomes of DFUs. In prior work our laboratory has examined the effect...

Full description

Bibliographic Details
Main Authors: Ramanjot Kaur, Catherine Tchanque-Fossuo, Kaitlyn West, Yasmin Hadian, Anthony Gallegos, Daniel Yoon, Ligia Ismailyan, Saul Schaefer, Sara E. Dahle, R. Rivkah Isseroff
Format: Article
Language:English
Published: BMC 2020-06-01
Series:Trials
Subjects:
Diabetic foot ulcer
Chronic wounds
Nonhealing wounds
Timolol
Randomized controlled trial
Online Access:http://link.springer.com/article/10.1186/s13063-020-04413-z

Similar Items

Similar Items